Webinar - The Development of Nanosuspension Formulations for Poorly Soluble Drugs

Laval, Quebec, January 4, 2022 – Altasciences, an integrated CRO/CDMO offering pharmaceutical and biotechnology companies a seamless solution to early-stage drug development from lead candidate selection to clinical proof of concept, announced today the completed acquisition of Sinclair Research, a preclinical CRO located in the Midwest. Complementing existing locations on the East and West Coast, the new site will facilitate even greater access to Altasciences’ preclinical services across the U.S.

We provide proof of concept, R&D, clinical and commercial manufacturing, that includes liquid-filled capsules, band/sealing technologies, powder and over-encapsulated capsules, topical formulations, and clinical and blister packaging, manufactured in our purpose-built facility that includes state-of-the-art ISO 7 and ISO 8 cleanrooms. 

White Paper Nanomilling 

Altasciences’ pharmaceutical contract development manufacturing organization (CDMO) has deep expertise and capabilities across a range of dosage forms.
All of our processes are supported by U.S.- and EU-compliant cGMP procedures, in conjunction with a robust, on-going training program. Our facility and equipment are designed, built, and fully qualified to meet and/or exceed all current regulations and guidance. We are agile, flexible, and always available. Analytical services include development and validation of methodologies, and a range of product-release testing.

Our GMP facility features an analytical lab, R&D formulations lab, multiple manufacturing suites, including segregated and dedicated potent handling capabilities, and a warehouse.

Our pharmaceutical contract manufacturing expertise includes liquid and powder-filled capsules, nanomilled suspensions, creams, gels, powders, and terminally sterilized injectables, which are manufactured in our purpose-built facility with state-of-the-art Grade C cleanrooms. We handle APIs/HPAPIs from formulation through commercial scale and offer analytical method development, qualification, and validation for the in-process and finished product, as well as ICH stability storage.

Altasciences is an integrated drug development solution company, offering pharmaceutical and biotechnology companies of all sizes a proven, flexible approach to their preclinical and clinical study needs. From lead candidate selection to proof of concept, we offer one-stop integrated formulation, preclinical and clinical manufacturing and analytical services. For over 25 years, Altasciences has been integrating into clients’ projects to help support educated, faster, and more complete early drug development decisions. Altasciences’ full-service solutions include preclinical safety testing, clinical pharmacology, bioanalysis, program management, medical writing, biostatistics, and data management, all of which can be tailored to specific sponsor requirements.

Altasciences… helping sponsors get better drugs to the people who need them, faster. 

Discover how Altasciences' CDMO services set the foundation for quality and expertise. In a new interview, Vice President of Manufacturing, Ben Reed, discusses Altasciences' unique drug manufacturing capabilities, talent acquisition, and running niche programs.